Advanced Oral Pain Relief Systems and Methods

Publication ID: 24-11857676_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Advanced Oral Pain Relief Systems and Methods,” Published Technical Disclosure No. 24-11857676_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857676_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,676.

Summary of the Inventive Concept

This inventive concept discloses novel systems, methods, and compositions for rapid and effective oral pain relief, addressing the limitations of existing treatments by providing customizable, temperature-controlled, and pH-sensitive solutions.

Background and Problem Solved

The original patent, 'Compositions for oral pain relief', provides a foundation for oral pain relief using dissolvable compositions. However, it has limitations in terms of application, bioavailability, and customization. The new inventive concept addresses these limitations by introducing advanced systems and methods that enhance the delivery, efficacy, and personalization of oral pain relief.

Detailed Description of the Inventive Concept

The inventive concept comprises four key aspects: (1) a temperature-controlled applicator for precise and efficient delivery of the composition; (2) a pH-sensitive component that enhances the bioavailability of active ingredients in the oral cavity; (3) a controlled-release mechanism for delivering a predetermined amount of the composition; and (4) a method for customizing oral pain relief compositions based on a subject's specific oral pain condition. These advancements enable rapid, targeted, and effective oral pain relief.

Novelty and Inventive Step

The new claims introduce novel and non-obvious elements, including the temperature-controlled applicator, pH-sensitive component, controlled-release mechanism, and customization method. These elements, individually and in combination, provide a significant improvement over the original patent, offering a more efficient, effective, and personalized approach to oral pain relief.

Alternative Embodiments and Variations

Alternative embodiments may include variations in the composition's carrier, active ingredients, and pH-sensitive component. Additionally, the temperature-controlled applicator could be replaced with other delivery mechanisms, such as ultrasonic or jet-based systems. The customization method could also be adapted for use with other types of pain relief or medical treatments.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the oral healthcare industry, particularly in the areas of dental care, pain management, and medical devices. The target market includes dental professionals, pharmaceutical companies, and medical device manufacturers seeking to develop and market innovative oral pain relief solutions.

CPC Classifications

SectionClassGroup
A A61 A61K9/006
A A61 A61K31/045
A A61 A61K31/047
A A61 A61K31/085
A A61 A61K36/53
A A61 A61K36/534
A A61 A61K36/9064
A A61 A61K47/10
A A61 A61K47/26
A A61 A61P23/02

Field of Art

Pharmaceutical compositions for oral pain relief, specifically focused on topical analgesic formulations with natural ingredient combinations and delivery mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A pharmacist, pharmaceutical formulation specialist, or medical researcher with expertise in oral pain management, natural ingredient interactions, and drug delivery systems, possessing knowledge of herbal extracts, carrier technologies, and pain relief composition design

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's specific oral pain relief composition provides a foundational framework that can be predictably extended through known pharmaceutical formulation techniques. The PTD's variations represent standard engineering design choices and incremental improvements that would be apparent to a skilled practitioner seeking to optimize oral pain treatment delivery and effectiveness.

Obvious Combinations & Variations

Source Patent Element
Dissolvable composition with specific active ingredients like guaiacol, eugenol, and glycerin
PTD Variation
Adding temperature-controlled applicator and pH-sensitive delivery mechanism
Obviousness Reasoning
Modifying drug delivery mechanisms is a predictable variation in pharmaceutical formulation, with known techniques for improving ingredient bioavailability and targeted application
Source Patent Element
Carrier comprising xylitol and aloe
PTD Variation
Customizable carrier tailored to specific oral pain conditions
Obviousness Reasoning
Personalized medicine approaches are well-established, and adapting carrier compositions based on patient-specific requirements represents an obvious extension of existing pharmaceutical design principles
Source Patent Element
Composition with defined percentages of active ingredients
PTD Variation
Controlled-release mechanism for delivering predetermined composition amounts
Obviousness Reasoning
Precise dosage control is a standard pharmaceutical engineering goal, and developing mechanisms to regulate ingredient release would be an obvious improvement to existing formulations
Source Patent Element
Natural oil-based active ingredients
PTD Variation
Alternative delivery systems like ultrasonic or jet-based application methods
Obviousness Reasoning
Exploring multiple application technologies for natural ingredient compositions is a routine design optimization approach in pharmaceutical development
Source Patent Element
Oral pain relief composition
PTD Variation
pH-sensitive component enhancing bioavailability of active ingredients
Obviousness Reasoning
Improving ingredient absorption through pH modulation is a known pharmaceutical technique, representing a predictable enhancement to existing formulation strategies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857676 and the disclosed variations, a person having ordinary skill in pharmaceutical formulation would find the claimed innovations obvious and anticipated, as the technical extensions represent predictable design choices and incremental improvements within the established pharmaceutical oral pain relief composition domain.

Original Patent Information

Patent NumberUS 11,857,676
TitleCompositions for oral pain relief
Assignee(s)ORCA PRODUCTS, LLC